| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/09/1998 | CN1192654A Novel embolizing compositions |
| 09/09/1998 | CN1192436A New-benzylpiperazine compounds, process for their prepn. and pharmaceutical compositions which contain them |
| 09/09/1998 | CN1192357A New use of caffeic acid and ferulic acid antagonistic endotheliolysin biological effect |
| 09/09/1998 | CN1039714C Substituted indole derivatives, prepn. method and application thereof |
| 09/08/1998 | US5804599 Oxabicyclo(4.1.0)heptane derivatives; antibacterial agents |
| 09/08/1998 | US5804562 Treatment of hypercholesterolemia or atherosclerosis |
| 09/08/1998 | US5804554 Calcium channel blocking polypeptides from filistata hibernalis |
| 09/08/1998 | US5804550 Peptide antagonists at glutamate and NMDA receptors |
| 09/08/1998 | US5804399 Incubation; measuring effect of composition on kinase or polynucleotide encoding the kinase |
| 09/08/1998 | US5804204 Potassium salts for treatment of hypertension |
| 09/08/1998 | CA2083475C Derivatives of ethanolamine, their preparation, and the pharmaceutical compositions containing them |
| 09/03/1998 | WO1998038305A1 Physiologically active protein originating in mammals |
| 09/03/1998 | WO1998038194A1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 09/03/1998 | WO1998038187A1 Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions |
| 09/03/1998 | WO1998038186A1 Quinoxalinediones |
| 09/03/1998 | WO1998038165A1 S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
| 09/03/1998 | WO1998038163A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | WO1998038155A1 5-hydroxymethyl-2-aminotetralins as cardiovascular agents |
| 09/03/1998 | WO1998038154A1 Hydroxymethyl derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene as cardiovascular agent |
| 09/03/1998 | WO1998037894A1 Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists |
| 09/03/1998 | WO1998037880A1 Inhibitors of leaderless protein export |
| 09/03/1998 | WO1998037877A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | WO1998008855A3 N6 heterocyclic substituted adenosine derivatives |
| 09/03/1998 | CA2282656A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | CA2282655A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | CA2282557A1 Physiologically active protein originating in mammals |
| 09/03/1998 | CA2282455A1 Hydroxymethyl derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene as cardiovascular agent |
| 09/03/1998 | CA2282388A1 5-hydroxymethyl-2-aminotetralins as cardiovascular agents |
| 09/03/1998 | CA2281925A1 Inhibitors of leaderless protein export |
| 09/02/1998 | EP0861850A1 Tumor necrosis related receptor, TR4 |
| 09/02/1998 | EP0861836A1 Sulfonamido substituted condensed, seven-membered ring compounds with potassium channel blocking activity |
| 09/02/1998 | EP0861260A1 Improved method and agents for inhibiting protein aging |
| 09/02/1998 | EP0861257A1 Spiro piperidine derivatives as 5mt receptor antagonists |
| 09/02/1998 | EP0861253A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/02/1998 | EP0861250A1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |
| 09/02/1998 | EP0861247A1 Novel imidazole n-benzyldioxol derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists |
| 09/02/1998 | EP0861238A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 09/02/1998 | EP0861082A1 Therapy for tissue membrane insufficiency |
| 09/02/1998 | EP0861074A1 Non-ionic surfactant vesicles as therapeutic agent |
| 09/02/1998 | EP0861070A2 Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis |
| 09/02/1998 | EP0686044B1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors |
| 09/02/1998 | CN1192207A 2-substituted benzimidazole derivatives as inhibitors of smooth muscle cell proliferation |
| 09/02/1998 | CN1192206A Styryl benzimidazole derivatives as inhibitors of smooth muscle cell proliferation |
| 09/02/1998 | CN1192205A Benzimidazole derivatives as inhibitors of smooth muscle cell proliferation |
| 09/02/1998 | CN1192204A 2-substituted benzimidazole derivatives as smooth muscle cell proliferation inhibitors |
| 09/02/1998 | CN1192202A Diheterocyclic acrylonitriles as smooth muscle cell proliferation inhibitors |
| 09/02/1998 | CN1192147A Imidazole compounds |
| 09/02/1998 | CN1192144A 1H-4(5)-substituted imidazole derivatives |
| 09/02/1998 | CN1192140A Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels |
| 09/02/1998 | CN1192121A Modulation of calcium channels |
| 09/02/1998 | CN1191862A 8-substituted-1,3,8-triaza-spiro £4,5| decan-4-on derivatives |
| 09/02/1998 | CN1039622C New use for large ring lactone compound |
| 09/01/1998 | USRE35886 Endothelin-converting enzyme inhibitor |
| 09/01/1998 | US5801199 Pharmaceutical composition for treating acute rhinitis |
| 09/01/1998 | US5801198 Retarding neutrophil infiltration ad morphologic reduction in ischemic bowel tissues |
| 09/01/1998 | US5801180 Antiischemic agents and cardiovascular disorders |
| 09/01/1998 | US5801179 Treatment of migraines, hypotension, venous insufficiency |
| 09/01/1998 | US5801174 Cerebrovascular disorders |
| 09/01/1998 | US5801170 Heterocyclic biphenylylamides useful as 5HT1D antagonists |
| 09/01/1998 | US5801162 Containing tissue plasminogen activator |
| 09/01/1998 | US5801156 Macular degeneration |
| 09/01/1998 | US5801148 Serine protease inhibitors-proline analogs |
| 09/01/1998 | US5801044 Nucleic acid encoding an antibody that inhibits cell adhesion protein-carbohydrate interactions |
| 09/01/1998 | US5801012 Methods and compositions for generating angiostatin |
| 09/01/1998 | US5800835 Preparation for improving the blood supply containing hard magnetic particles |
| 09/01/1998 | CA2166903C 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 08/27/1998 | WO1998037079A1 N-heterocyclic derivatives as nos inhibitors |
| 08/27/1998 | WO1998037075A1 Disubstituted bicyclic heterocycles, their production and use as medicaments |
| 08/27/1998 | WO1998037061A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 08/27/1998 | WO1998036777A1 Site-specific drug delivery |
| 08/27/1998 | WO1998036770A1 Preparations for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor |
| 08/27/1998 | WO1998036747A1 Pharmaceutical composition |
| 08/27/1998 | WO1998036733A2 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 08/27/1998 | WO1998027930A3 New use of aminopiperazine derivatives |
| 08/27/1998 | WO1998024782A3 Substituted pyrimidine compounds and their use |
| 08/27/1998 | WO1998006437A3 Compositions and methods for polynucleotide delivery |
| 08/27/1998 | CA2554085A1 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 08/27/1998 | CA2282467A1 Preparations for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor |
| 08/27/1998 | CA2281493A1 Site-specific drug delivery |
| 08/26/1998 | EP0860506A1 Human protein kinase hYAKI (HOACF 72) |
| 08/26/1998 | EP0860445A1 New nucleotide sequences for the cell cycle regulated expression of structural genes |
| 08/26/1998 | EP0860440A1 Sulfonamido substituted chromane derivatives with potassium channel blocking activity |
| 08/26/1998 | EP0859853A1 Method for transferring genes to the heart using aav vectors |
| 08/26/1998 | EP0859834A2 A paf-acetylhydrolase and use in therapy |
| 08/26/1998 | EP0859787A1 G-protein coupled receptor hnfds78 |
| 08/26/1998 | EP0859784A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 08/26/1998 | EP0859779A1 Interleukin converting enzyme and apoptosis |
| 08/26/1998 | EP0859771A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use |
| 08/26/1998 | EP0859763A1 Dihydrophthalazine antagonists of excitatory amino acid receptors |
| 08/26/1998 | EP0859762A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification |
| 08/26/1998 | EP0859760A1 Tricyclic pyrrolidine derivatives as calcium channel antagonists |
| 08/26/1998 | EP0859639A1 Methods for treating cancers and restenosis with p21 |
| 08/26/1998 | EP0859622A1 Extracts of shark cartilage |
| 08/26/1998 | EP0859620A1 Nitrogen monoxide composition for use as a drug |
| 08/26/1998 | EP0859607A1 Guanidino protease inhibitors |
| 08/26/1998 | EP0767787B1 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants |
| 08/26/1998 | EP0741715B1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use |
| 08/26/1998 | EP0739336B1 Gem-disubstituted azacyclic tachykinin antagonists |
| 08/26/1998 | EP0673360B1 Aminomethylindans, -benzofuranes and -benzothiophenes |
| 08/26/1998 | CN1191533A 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivs. as neurokinin receptor antagonists |